Mefloquine synergism with anti-tuberculosis drugs and correlation to membrane effects: Biologic, spectroscopic and molecular dynamics simulations studies

Author:

dos Santos Marinalva Cardoso,Scaini João Luís Rheingantz,Lopes Márcio Vinicius Costa,Rodrigues Beatriz Gonçalves,Silva Nichole Osti,Borges Carla Roberta Lopes,dos Santos Sandra Cruz,dos Santos Machado Karina,Werhli Adriano Velasque,da Silva Pedro Eduardo Almeida,Lourenço Maria C.S.,da Silva Emerson T.,de Souza Marcus V.N.,de Lima Vânia Rodrigues,Gonçalves Raoni Schroeder B.

Funder

CNPq

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Molecular Biology,Biochemistry

Reference75 articles.

1. World Health Organization, Global tuberculosis report 2019, Geneva, 2019.

2. Early outcomes in MDR-TB and XDR-TB patients treated with delamanid under compassionate use;Hafkin;Eur. Respir. J.,2017

3. Repurposing-a ray of hope in tackling extensively drug resistance in tuberculosis;Maitra;Int. J. Infect. Dis.,2015

4. Is repositioning of drugs a viable alternative in the treatment of tuberculosis?;Palomino;J. Antimicrob. Chemother.,2013

5. New and repurposed drugs to treat multidrug- and extensively drug-resistant tuberculosis;Silva;Jornal Brasileiro de Pneumologia.,2018

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3